Cargando…
The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
The coronavirus disease 2019 (COVID-19) pandemic has shattered the meticulously developed processes by which we delivered quality care for patients with cirrhosis. Care has been transformed by the crisis, but enduring lessons have been learned. In this article, we review how COVID-19 will impact cir...
Autores principales: | Tapper, Elliot B., Asrani, Sumeet K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194911/ https://www.ncbi.nlm.nih.gov/pubmed/32298769 http://dx.doi.org/10.1016/j.jhep.2020.04.005 |
Ejemplares similares
-
Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022) -
Will COVID-19 Have Long-Lasting Effects on Inequality? Evidence from Past Pandemics
por: Furceri, Davide, et al.
Publicado: (2022) -
Acute Alcohol-Associated Hepatitis in the COVID-19 Pandemic — a Structured Review
por: Schulz, Philipp, et al.
Publicado: (2022) -
Medically tailored meals for the management of symptomatic ascites: the SALTYFOOD pilot randomized clinical trial
por: Tapper, Elliot B, et al.
Publicado: (2020) -
Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives
por: Wolff, Andreas Wolfgang, et al.
Publicado: (2023)